PL
Polaryx Therapeutics, Inc. Common Stock (PLYX)
NASDAQ·Healthcare·Biotechnology
$1.85
+6.32%
Mkt Cap $240.03M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$6.50
Range $6.00 – $7.00
Implied Upside
+251.4%
Consensus $6.50 vs current $1.85